Volume 95 of International Review of Neurobiology focuses on Catechol-O-methyltransferase inhibition, and its clinical application in relation to Parkinson''s disease. Chapters cover COMT gene and proteins, L-dopa treatment in Parkinson''s disease, the latest research on COMT inhibitors and their clinical applications, as well as future prospects for their use.- Up-to-date summary of biochemistry and pharmacology of COMT and its inhibitors- Preclinical models in COMT inhibitor devlopment- Transgenic COMT mice – latest information summarized- Chemistry of COMT inhibitors and their design with molecular modelling- COMT gene and its regulation and relation to dopamine related diseases- Role of cofactor SAM regulation in relation to homocysteine- Nonclinical and clinical safety of COMT inhibitors summarized- Future prospects of COMT inhibitors in Parkinson''s disease
Our site uses cookies and similar technologies to offer you a better experience. We use analytical cookies (our own and third party) to understand and improve your browsing experience, and advertising cookies (our own and third party) to send you advertisements in line with your preferences. To modify or opt-out of the use of some or all of our cookies, please go to “Manage Cookies” or view our Cookie Policy to find out more. By clicking “Accept all” you consent to the use of these cookies.